Provided by Tiger Trade Technology Pte. Ltd.

Insmed

118.54
-2.8500-2.35%
Pre-market: 119.000.4600+0.39%07:00 EDT
Volume:1.98M
Turnover:234.89M
Market Cap:25.89B
PE:-29.00
High:120.66
Open:120.11
Low:117.15
Close:121.39
52wk High:212.75
52wk Low:90.39
Shares:218.38M
Float Shares:216.82M
Volume Ratio:1.26
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.0882
EPS(LYR):-6.4200
ROE:-87.22%
ROA:-22.17%
PB:34.17
PE(LYR):-18.46

Loading ...

Movement Alert|Insmed Rises 5.87% in Pre-Market Trading, Core Drug Brinsupri Approved in Japan

Market Focus
·
Aug 28

RBC Capital Reaffirms Their Buy Rating on Insmed (INSM)

TIPRANKS
·
Aug 27

Insmed to Present at Cantor Fitzgerald Global Healthcare Conference

Reuters
·
Aug 26

U.S. Research Roundup-Masco, Sherwin-Williams, Vulcan Materials

Reuters
·
Aug 25

Insmed Stock Seen by Mizuho as Undervalued

Dow Jones
·
Aug 25

Insmed Earns Buy Rating as Brinsupri Japan Approval Drives Stronger Global Outlook and Price Target Raised to $195

TIPRANKS
·
Aug 25

Mizuho ups Insmed price target, says share weakness is unwarranted

TIPRANKS
·
Aug 25

Insmed's Lung Disease Drug Gets Approved in Japan

MT Newswires Live
·
Aug 24

Insmed Says Japan Health Ministry Approves Brinsupri for Non-Cystic Fibrosis Bronchiectasis

Reuters
·
Aug 24

Brinsupri® (Brensocatib) Approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients with Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease

THOMSON REUTERS
·
Aug 24

Insmed Director Melvin Sharoky, M.D. Sells 5,000 Shares for $637,650

Reuters
·
Aug 20

Analysts Are Bullish on These Healthcare Stocks: ACADIA Pharmaceuticals (ACAD), Insmed (INSM)

TIPRANKS
·
Aug 18

Insmed (INSM) Earnings Narrow Losses As Fair Value Comes Back Into Focus

Simply Wall St.
·
Aug 18

Insmed Extends Its Pulmonary Hypertension Push With Long-Term TPIP Study

TIPRANKS
·
Aug 14

Top Insmed Executive Executes Major Multi-Million Dollar Stock Move

TIPRANKS
·
Aug 13

Insmed COO Roger Adsett Sells 239,850 Shares for $31.97 Million

Reuters
·
Aug 13

Insmed Price Target Raised to $195.00/Share from $185.00 by Truist Securities

Dow Jones
·
Aug 11

Truist Financial Remains a Buy on Insmed (INSM)

TIPRANKS
·
Aug 10

Is Insmed (INSM) Cheap After Q2 Revenue Growth And Raised Guidance?

Simply Wall St.
·
Aug 09

Insmed Chief Medical Officer Martina Flammer Disposes of Common Shares Worth $3.5 Million

Reuters
·
Aug 08